{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:39:29Z","timestamp":1788377969424,"version":"build-2803163510"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.2169\/internalmedicine.0317-17","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T22:36:37Z","timestamp":1535063797000},"page":"109-113","source":"Crossref","is-referenced-by-count":6,"title":["Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome"],"prefix":"10.2169","volume":"58","author":[{"given":"Kiyohito","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Tasaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"},{"name":"Department of Transfusion Medicine, Saitama Medical Center, Saitama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology\/Orthopedic Surgery, East Medical Center, Tokyo Women's Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Matsuhashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Sadahira","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideho","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Goto M, Miller RW, Ishikawa Y, et al. Exess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5: 239-246, 1996."},{"key":"2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1345::AID-CNCR18>3.0.CO;2-#","volume":"85","author":"Y Ishikawa","year":"1999","unstructured":"2. Ishikawa Y, Sugano H, Matsumoto T, et al. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 85: 1345-1352, 1999.","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sugimoto M, Fruichi Y, Ide T, Goto M. Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (review). Oncol Lett 2: 609-611, 2011.","DOI":"10.3892\/ol.2011.298"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bj\u00f6rnberg A. Werner&apos;s syndrome and malignancy. Acta Derm Venereol 56: 149-150, 1976.","DOI":"10.2340\/0001555556149150"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sato K, Goto M, Nishioka K, et al. Werner&apos;s syndrome associated with malignancies: five case reports with a survey of case histories in Japan. Grontology 34: 212-218, 1988.","DOI":"10.1159\/000212956"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Seiter K, Qureshi A, Liu D, et al. Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner&apos;s syndrome. Leuk Lymphoma 46: 1091-1095, 2005.","DOI":"10.1080\/10428190500102688"},{"key":"7","unstructured":"7. [The practice guideline for Werner syndrome] Yokote K, Ed. [Internet]. [cited 2018 Apr. 10]. Available from: http:\/\/www.m.chiba-u.jp\/dept\/clin-cellbiol\/files\/5215\/0752\/8288\/guideline.pdf (in Japanese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takemoto M, Mori S, Kuzuya M, et al. Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey. Geriatr Gerontol Int 13: 475-481, 2013.","DOI":"10.1111\/j.1447-0594.2012.00913.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sadahira Y, Sugihara T, Goto M, et al. WRN protein as a novel erythroblast immunohistochemical marker with applications for the diagnosis of Werner syndrome. Virchows Arch 466: 343-350, 2015.","DOI":"10.1007\/s00428-014-1703-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yokote K, Chanprasert S, Lee L, et al. WRN mutation update: mutation spectrum, patient registries, and translational prospects. Hum Mutat 38: 7-15, 2017.","DOI":"10.1002\/humu.23128"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Huang S, Lee L, Hanson NB, et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 27: 558-567, 2006.","DOI":"10.1002\/humu.20337"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Monnat RJ Jr. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol 20: 329-339, 2010.","DOI":"10.1016\/j.semcancer.2010.10.002"},{"key":"13","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"13. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106: 2912-2919, 2005.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.leu.2404037","volume":"20","author":"A Shimoni","year":"2006","unstructured":"14. Shimoni A, Hardan I, Shem-Tov N, et al. Allogeneic hematopoietic stem cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia 20: 322-328, 2006.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamamoto H, Uchida N, Yuasa M, et al. A novel reduced-toxicity myeloablative conditioning regimen using full-dose busulfan, fludarabine, and melphalan for single cord blood transplantation provides durable engraftment and remission in nonremission myeloid malignancies. Biol Blood Marrow Transplant 22: 1844-1850, 2016.","DOI":"10.1016\/j.bbmt.2016.06.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamamoto H, Uchida N, Matsuno N, et al. I.v. BU\/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high risk hematological disease. Bone Marrow Transplant 50: 607-609, 2015.","DOI":"10.1038\/bmt.2014.316"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ciurea SO, Andersson BS. Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15: 523-536, 2009.","DOI":"10.1016\/j.bbmt.2008.12.489"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Abedin S, Peres E, Levine JE, et al. Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation. Biol Blood Marrow Transplant 20: 2062-2066, 2014.","DOI":"10.1016\/j.bbmt.2014.07.014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sanz J, Boluda JC, Martin C, et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine, and ATG as myeloablative conditioning regimen. Bone Marrow Transplant 47: 1287-1293, 2012.","DOI":"10.1038\/bmt.2012.13"},{"key":"20","unstructured":"21. Taketomi K, Goto Y, Arai I, Ichinose M, Kinoshita K. An autopsy case of Werner&apos;s syndrome associated with meningioma and myelodysplastic syndrome. To-Nyo-Byo 33: 180, 1990 (in Japanese)."},{"key":"21","unstructured":"22. Sakagami Y, Kato Y, Hatta K, Kusumi F, et al. A case of Werner&apos;s syndrome associated with RAEB and myelofibrosis. Naika Hokan 37: 295, 1990 (in Japanese)."},{"key":"22","doi-asserted-by":"publisher","unstructured":"23. Mita M, Ishibashi T, Shichishima T, Maruyama Y. Myelodysplastic syndrome with multiple chromosome aberrations in a patient with Werner&apos;s syndrome. Rinsho Ketsueki 37: 725-730, 1996 (in Japanese, Abstract in English).","DOI":"10.11406\/rinketsu.37.725"},{"key":"23","unstructured":"24. Arai H, Saito Y, Uzuka Y, et al. A case of Werner&apos;s syndrome in association with leukemia. Tohoku Igaku Zasshi 96: 34-39, 1983 (in Japanese, Abstract in English)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Undar L, Karadogan I, Artvinli M, Karpuzoglu G. Myelodysplastic syndrome in a patient with Werner&apos;s syndrome. Acta Haematol 92: 150-153, 1994.","DOI":"10.1159\/000204208"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Ochi M, Igase M, Nagai A, et al. A case of Werner syndrome with chromosomal abnormality. Nihon Ronen Igakkai Zasshi (Jpn J Geriatr) 43: 639-642, 2006 (in Japanese, Abstract in English).","DOI":"10.3143\/geriatrics.43.639"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/1\/58_0317-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:53:21Z","timestamp":1693839201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/1\/58_0317-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0317-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}